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Abstract
Polyurethanes is a group of polymers whose unique properties make them useful in
both the construction and the textile industry, and even in tissue engineering. One
small, but very significant, urethane group connects specially selected macrochains
to obtain a material with established properties.
The chapter is a literature review for research on the synthesis and properties of new
degradable polyurethanes that contain soft segments synthesized with synthetic
telechelic poly([R,S]-3-hydroxybutyrate) (R,S-PHB). Incorporation of oligomeric R,S-
PHB (what was found degradable and biocompatible) into polyurethane structures
gives them a chance of improving the properties important for medical applications.
Aliphatic and aromatic polyurethanes with different soft segments were investigated
due to their potential to be used in soft tissue regeneration.
Keywords: Polyurethanes, synthetic polyhydroxybutyrate, medical application
1. Introduction
Polyurethane (PUR) is a large and very diverse group of polymers, including elastomeric and
thermoplastic materials (liquid, millable), foams, and ionomers in the aqueous dispersions [1–
3]. The preparation of polyurethanes in such various forms has allowed their broad use in such
industries as construction, engineering, automotive, textile, and medical. In medicine, their
biocompatible, biostatic, and biodegradable properties are very desirable. The required
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properties can be achieved using appropriate monomers for polyurethane synthesis and for
preparing their composites.
1.1. Polyurethanes in medicine
PURs’ career in medicine has been going for almost 60 years since polyurethane foam for breast
implants has been patented [4, 5]. According to studies of Jose Abel de la Pen˜a-Salcedo et al.
[6] performed at the Institute for Plastic Surgery, polyurethane-covered implants are still the
best option for breast reconstruction.
PURs are already used or investigated for utilization as membranes for wound dressing [7],
as meniscal scaffold to treat partial meniscal loss [8], as drug nanocarriers for endovascular
applications [9], as controlled release membrane system for delivery of ketoprofen [10], or as
the biostable polyurethane/hydroxyapatite composites for bone replacement materials [11].
Whereas the shape memory PUR (based on PCL) used as wire in orthodontic appliance, could
effectively align the teeth [12]. Waterborne polyurethane with chitosan as chain extender was
also studied as antimicrobial agent for acrylic fabrics that could be used for the manufacture
of blankets and carpets in hospitals [13].
One of the most important uses of PURs in medicine is the preparation of the implants for
cardiovascular diseases, the use of which the specific properties of PUR (high mechanical
strength, toughness and flexibility without the addition of modifiers, and good hemocompat‐
ibility resulting from occurring on the surface hydrophilic-hydrophobic balance) are very
important.
1.2. Polyurethanes biostatic and biocidic
The very important danger during implantation is connected with bacterial and fungi
contamination. Aside from antibiotics treatment after surgery, the use of biostatic implant is
essential for the success implantation.
The bacterial adherence and encrustation was reduced after the immobilization on PUR
(Tecoflex®) surface by polyvinylpyrrolidone-iodine (PVP-I) complex [14]. Modified films were
much more hydrophilic than original films.
Surfaces coated with quaternized PUR possessed the antibacterial and antiviral properties [15].
For wound dressing application, the asymmetric PUR membrane, with diamino containing
antibiotic sulphanilamide used as a chain extender could be utilized [16]. These antibiotic-
conjugated PUR are enzymatic susceptible what fit them antibacterial activity. The antibacte‐
rial properties can also be achieved by using nanoparticles for polyurethane or its composites
obtaining. The nanosilver nanoparticles are very often used [17].
1.3. Biodegradable polyurethanes
The first applications of polymers required their high resistance to environmental factors. They
had to be stable (non-degradable) under the operating conditions throughout. This applies to
the construction, packaging, textile, mechanical, medical, as well as other industries. However,
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the growing environmental burden of polymer waste has caused plastics to be gradually
replaced by degradable materials. In medicine, dynamically developing tissue engineering
suggests many interesting solutions with biodegradable polymeric materials.
PURs were originally considered to be very resistant to environmental impacts and were used
in the construction of the first "artificial hearts". So why not produce something biocompatible
as polyurethane and simultaneously degradable for tissue reconstruction? Since the first time
this question was formulated, a lot of really interesting investigations were conducted.
The use of monomers susceptible to environmental factors allows the production of biode‐
gradable PURs potentially suitable to create scaffolds for the growth of living cells or as
temporary implants. Hydrolysis-sensitive ester groups, mostly with oligomerols, are intro‐
duced into the PUR structure to build the soft segments.
Wang and co-workers [18] synthesized biodegradable polyurethanes with 11,11’-dithiodiun‐
decanol employed as a soft segment. They concluded that the molecular weight of PURs
substantially decreased and the surface morphology was significantly eroded after 8 days of
incubation in SBF with reduced glutathione. Gisele Rodrigues da Silva et al. [19] observed that
the biodegradable PURs based on PCL were able to release dexamethasone acetate for 371 days
at almost constant rates.
1.4. Polyurethanes that are more biocompatible
Using of natural components (or their synthetic substitutes) for PURs synthesis is one of
method for making them more biocompatible. Saralegi et al. used castor oil for soft segment
building [20]. They obtained the shape memory thermoplastic PUR due to the addition of
cellulose nanocrystals. L-arginine, glycine, and L-aspartic acid were used as chain extenders
in poly(urea)urethanes synthesis by the Chan-Chan group [21]. The authors concluded that
PURs containing L-arginine would be a potential candidate for cardiovascular applications
and angiogenesis. Studies of Lin Jia and co-workers [22] showed the lack of cytotoxicity of
PUR/collagen and PUR/gelatin nanofibrous scaffolds. The authors indicated on sufficient
mechanical properties, supported SMC proliferation, and assisted in oriented morphological
alignment of cells of PURs with L-arginine that make them the appropriate candidate for
vascular tissue engineering.
Very important for obtaining biocompatible material is the use for their synthesis substrates
that are non-toxic and degraded into non-toxic compounds. In medical applications, 4,4'-
methylene dicyclohexyl diisocyanate (H12MDI) successfully replaced 4,4'-diphenylmethane
diisocyanate (MDI), especially in the synthesis of biodegradable materials, thereby reducing
the risk of creation of carcinogenic aromatic diamine as degradation product of PUR based on
MDI.
Using natural components for polyurethanes building very often gives them a chance to be
biocompatible and degradable simultaneously. The important groups of substrates useful for
polyurethanes synthesis are polyhydroxyacids (PHA). Among them, polyhydroxybutyrate
(PHB) is the most often used.
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1.5. Biosynthesized polyhydroxybutyrate
As it was mentioned before, the most popular polyhydroxyacid is PHB. Since the 1920s when
Lemoigne found the bacterial granules of supplementary material (later called polyhydroxy‐
butyrate) in Bacillus megaterium, intensive researches on the biological and chemical obtaining
of PHB, its properties, and application were conducted. The natural origin, biodegradability,
and biocompatibility of polyhydroxybutyrate made it such interesting material for medical
applications whereas its low water vapor permeability, which is close to that low-density
polyethylene, promote it to food packaging applications [23].
PHB  degrades  into  3-hydroxybutyric  acid,  a  common  metabolite  in  human  blood.  3-
hydroxybutyric  acid  is  produced  in  ketone  bodies  of  mammals  during  the  prolonged
starvation  [24].  3-hydroxybutyric  acid  belongs  to  short-chain  fatty  acids  and  reveals
antibacterial activity [25].
A lot of investigations suggest that PHB is non-genotoxic [26].  All this features promote
PHB for medical applications. Lee and co-workers prepared a carrier system with target‐
ing capability for imaging and drug delivery to cancer cells using catalytic characteristics
of PHA synthase [27]. They found an attractive way of preparing functionalized nanopar‐
ticles by effective coupling between the hydrophobic surface of PHB nanoparticle and PHB
chain grown from the fusion enzyme. Medvecký and co-workers [28] found that the addition
of  hydrophobic  PHB  microparticles  into  the  calcium  phosphate  cement  significantly
improves the initial cement properties (the higher tensile and compressive strengths) and
makes it a very promising material for bone substituting. Another way of PHB utilization
in tissue reconstruction is by using it as the PHB–chitosan biopolymer scaffolds [29], PHB-
calcium phosphate/chitosan barrier membrane [30],  hydroxyapatite/PHB composites [31],
or biodegradable stents [32]. The investigations of Shishatskaya at el. [33, 34] indicate that
PHB is a good candidate for fabricating prolonged-action drugs as microparticles intend‐
ed for intramuscular injection. Whereas Althuri and co-workers [35] concluded that folate
functionalized  PHB nanoparticles  can  be  used  as  a  polymer  matrix  to  carry  toxic  drug
compounds to targeted sites for treatment of life-threatening diseases such as cancer.
Nonetheless, the inherent brittleness and stiffness (connected to its semicrystalline nature)
and inferior thermal stability, in addition to relative high cost, have blocked the popular
use of PHB.
It is known that even the short exposure of PHB to temperatures near 180°C degrades it
to olefinic and carboxylic acid compounds (e.g., crotonic acid) and various oligomers. Also,
during storage,  the degree of crystallization of polymer increases and causes the forma‐
tion  of  irregular  pores  on  its  material  surface  and  causes  even  higher  stiffness.  These
disadvantages can be reduced by mixing of PHB with plasticizers, such as low molecular
weight  PHB  [36],  carboxyl-terminated  butadiene  acrylonitrile  rubber,  or  biocompatible
polyvinylpyrrolidone polymeric additives [37].
1.6. Chemically synthesized poly([R,S]-3-hydroxybutyrate)
The chemically synthesized substitute of natural PHB is synthetic poly([R,S]-3-hydroxybuty‐
rate) (R,S-PHB). Synthetic R,S-PHB can be obtained by anionic ring-opening polymerization
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of (R,S)-ß-butyrolactone. The supramolecular acid sodium salt complex of 3-hydroxybutyric
acid ether 18-crown-6 can then be used as the initiator. The polymerization process is carried
out in THF at room temperature. The resulting polymer could be reacted with 2-bromo- or 2-
iodoethanol, finally causing PHB to be terminated with hydroxy groups on both sides [38–41].
Figure 1. Scheme of how telechelic R,S-PHB (OH-terminated) and R,S-PHB (OH- and COOH-terminated) are obtained.
The literature indicated that materials obtained with synthetic R,S-PHB was biocompatible
and biodegradable. The degradation products of the temporary patch made from PHB/R,S-
PHB blends were metabolized and did not evoke inflammatory reactions [42]. Freier et al. [43]
found that after 26 weeks of implantation of the patches (made with PHB/R,S-PHB blends) in
the abdomen of rats, the loss of intestines of animals was almost completely restored and the
introduced material had been substantially degraded.
Piddubnyak et al.  [40] conducted a series of studies confirming the biocompatibility and
non-toxicity  of  synthetic  [R,S]-3-hydroxybutyrate  oligomerols.  The  possibility  of  their
formation into spherical particles of a diameter <1 micron, suggested that they could be
used  in  obtaining  nonsteroidal  anti-inflammatory  drugs.  In  the  form  of  an  aqueous
dispersion, they could be introduced into the body through intravenous, intramuscular, or
subcutaneous administration [44].
1.7. Marriage of PUR and PHB advantages in one product
Using for PUR synthesis, almost completely amorphous R,S-PHB that is close to its original
state in the cell, ought to be utilized to obtain biocompatible and biodegradable material useful
for medical application.
The work is a review of the research on the synthesis and properties of PURs containing
synthetic poly([R,S]-3-hydroxybutyrate) and polycaprolactonediol or polyoxytetramethyle‐
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nediol in soft segments in the structure in terms of applications as medical devices. The
properties of polyurethanes that could determine their usefulness for medical application
(structure, morphology of surface, thermal and mechanical properties, water and oil sorption,
density, degradability, spinnability, compatibility, and biostatic properties) were estimated.
Works with PURs based on natural and synthetic PHB are collected in Table 1.
Kind of PHB origin Characteristic Ref.
bacterial Higher crystallinity than PURs without PHB. [45]
bacterial (as copolymer P3/4HB) High molecular weight and narrow molecular weight distribution. [46]
bacterial (as copolymer P3/4HB) Narrow distribution and suitable crystallinity to prepare films and pads.
Non-toxic for cell growth and proliferation.
[47]
bacterial Degradability with creation of 3-hydroxybutyric acid and crotonic acid as
degradation products.
[48]
synthetic Hydrolytic degradation of PURs based on PCL/HB increased with
increasing of PHB fraction.
[49]
synthetic The way of PURs based on R,S-PHB obtaining. [50]
synthetic Presence of R,S-PHB influenced on the structure of PURs. [51]
synthetic Degradability of PURs increased after using of R,S-PHB for their building. [52]
synthetic Electrospinning of PURs based on R,S-PHB. [53]
synthetic Degradability of PURs increased after using of R,S-PHB for their building. [54]
Table 1. Polyurethanes based on PHB.
2. Experimental
2.1. Materials
Oligoesters, such as polycaprolactonediol (PCL) and polyhydroxybutyratediol (PHB), are used
in the synthesis of polyesterurethanes. The oxidative-sensitive ether groups can be introduced
into polyurethanes with polyoxytetramethylenediol (PTMG). 4,4'-diphenylmethane diisocya‐
nate (MDI) and 4,4'-methylene dicyclohexyl diisocyanate (H12MDI) are isocyanates that are
often used for building of hard segments of polyurethanes.
Aromatic and aliphatic polyurethanes with synthetic poly([R,S]-3-hydroxybutyrate) incorpo‐
rated into the soft segments structure were obtained and investigated.
2.1.1. Materials for polyurethanes synthesis
• Before the synthesis of polyurethanes, R,S-PHB (Mn~2000) (CMPW, PAN Zabrze), PCL
(Mn~2000) (Aldrich), and PTMG (Mn~2000) (Aldrich) were dried by heating at 60°C–90°C
for 3 h under reduced pressure;
• 4,4'-diphenylmethane diisocyanate MDI (Aldrich) was filtered and melted at temperature
40°C;
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• 4,4'-methylene dicyclohexyl diisocyanate (H12MDI) (Alfa Aesar) (mixture of isomers) was
purified via vacuum distillation;
• the chain extender 1,4-butanediol (1,4-BD) (Aldrich) was freed from moisture by an
azeotropic distillation with benzene prior to use;
• the solvent dimethylformamide (DMF) (Labscan Ltd) was dehydrated over P2O5 and
distilled under low pressure before synthesis; and
• catalysts dibutyltindilaurate (DBTDL) (Akra Chem) and stannous octoate (OSn) (Akra
Chem) were used as received. Stannous octoate was approved by the US Food and Drug
Administration as the catalyst for polyurethane synthesis [55].
2.1.2. Polyurethane synthesis and sample preparation
The synthesis of polyurethanes was carried out in a two-step reaction at the vacuum reactor,
as previously described [56].
First, the prepolymer was prepared from oligomerols and H12MDI or MDI, at 60°C–90°C in a
presence of a catalyst at reduced pressure according to the appropriate required molar ratio
of NCO:OH groups for 2–3 h. Oligomerols used in synthesis: a mixture of PCL and R,S-PHB
or a mixture of PTMG and R,S-PHB. For comparison, PURs based only on PCL or PTMG
without R,S-PHB were also obtained. The synthesis of prepolymer was carried on mass but
next the prepolymer was dissolved in DMF to solid mass concentration of 40%. The chain
extender (1,4-BD) was added to obtain equimolar ratio NCO:OH groups. The propagation
reaction of prepolymer was carried on for 2–3 h at 60°C.
PUR
Molar ratio of OH groups of reagents
used in PURs synthesis
Molar ratio
of NCO/OH in
prepolymer
(diisocyanate)
PCL R,S-PHB PTMG 1.4-BD
PUR-2A-1 - 0.23 0.77 2.7 3.7 (MDI)
PUR-2A-2 - - 1 2.7 3.7 (MDI)
PUR-2A-3 0.77 0.23 - 2.7 3.7 (MDI)
PUR-2A-4 1 - - 2.7 3.7 (MDI)
PUR-3A-1 - 0.23 0.77 2.7 3.7 (H12MDI)
PUR-3A-2 - - 1 2.7 3.7 (H12MDI)
PUR-3A-3 0.77 0.23 - 2.7 3.7 (H12MDI)
PUR-3A-4 1 - - 2.7 3.7 (H12MDI)
Table 2. Composition of the obtained polyurethanes.
After the extension of prepolymer chains, the solution of polyurethane was poured on Teflon
plates and heated for solvent evaporating (2 h/80°C). Next, the foils were heated in a vacuum
dryer for reaction completing (5 h/105°C). Before the estimation of polyurethanes properties,
the foils were conditioned at room temperature at least 2 weeks.
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The obtained and investigated PURs differed in soft and hard segment structures and in their
ratio (Table 2).
2.2. Methods of investigations, obtained results, and discussion
2.2.1. The structure of obtained polyurethanes
The structures of obtained aromatic and aliphatic PURs were investigated using FT-IR and
1HNMR methods (results presented in [51]).
The value of vibration absorption of the carbonyl group in the ester moiety at 1,740 cm-1 is
indicative of the presence of the amorphous phase of polyhydroxybutyrate (the presence of
the crystal phase of stretching vibration of C=O would be observed at 1,725 cm-1) [56, 57]. These
differences in the frequencies corresponding to the vibrations of the carbonyl bond were
explained by Wu and co-workers [58] by the decrease in oxygen dipole moment under the
influence of hydrogen from a neighboring chain. The interaction is stronger when the oxygen
is closer to the hydrogen atom. Amorphousness of R,S-PHB used in the synthesis of polyur‐
ethane, was also confirmed by the presence of bands of CH3 at 2,985 cm-1 and C-O-C stretching
vibration band at 1,186 cm-1 [57, 59]. It is known that asymmetric stretching vibration of CH3
at 3,009 cm-1, 2,995 cm-1, 2,974 cm-1, and 2,967 cm-1 in the natural polyhydroxybutyrate indicate
its crystallinity [57].
 
 
(a) 
 
(b) 
 
Figure 2. FT-IR spectra of substrates and PUR-3A-1 (a) and substrates and PUR-3A-3 (b).
FT-IR spectra supported the formation of urethane groups during polyaddition reaction of OH
groups of oligomerols (R,S-PHB, PCL, and PTMG) and NCO groups of diisocyanates (MDI
and H12MDI).
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In the spectra of PUR-2 and PUR-3 series with PTMG in soft segments (PUR-2A-2, PUR-2B-2,
PUR-3A-2 and PUR-3B-2), a single band (without shoulder) at around 3,330 cm-1 corresponded
to the NH stretching vibration of urethane groups. The absence of any bands above 3,500
cm-1 indicated that all group -NH were involved in the formation of hydrogen bonds.
Simultaneously, in an area corresponding to the stretching vibration of C=O groups of the
urethane two bands (at 1,720 cm-1/1,705 cm-1 for PUR-3 and at around 1,732 cm-1/1,703 cm-1 for
PUR-2) were observed. The intensities of these bands were comparable for PUR-3A-2. The
literature indicated that the first band corresponded to vibration of free groups C=O and the
other for associated groups [60]. The presence of free groups C=O suggested that not all -NH
were involved in the formation of hydrogen bonds within the urethane groups, but some of
them could be associated with the oxygen moiety of ether. The intensity of the absorption
bands of the C=O hydrogen bonded clearly decreased after the introduction of R,S-PHB into
the soft segments. On spectra PUR-3A-1 at 1,740 cm-1 appeared the band of stretching vibration
characteristic for non-hydrogen bonded C=O of ester groups.
In the spectra of all polyurethanes with PCL in their structure, there were clear bands of
stretching vibration characteristic for associated -NH. For polymers PUR-2 they were at 3,334
cm-1 and at about 3,360 cm-1 for PUR-3. At frequencies a bit lower, the presence of broad bands
with low intensity was also observed. It indicates the existence of two types of hydrogen bonds,
between the -NH groups and the carbonyl group of urethane and between -NH and ester
group. On the other hand, the intensity of the bands of stretching, hydrogen-bonded C=O of
urethane (amide I band) and ester groups on PUR-2A-3 and PUR-2A-4 spectra (at 1,702 cm-1
and 1,705 cm-1) was small.
Thus, the FT-IR spectra of the polyurethanes indicated that urethane groups (partly hydrogen
bonded) were formed and the end groups of substrates were completely converted.
On 1HNMR spectra of aliphatic PURs, peaks due to the NH group were observed in the region
of 6.6–7.1 ppm [51], whereas on the spectra of aromatic PUR they were located at 9.2–9.5 ppm.
The NH groups coming from urethane groups were forming hydrogen bonds with carbonyl
groups of ester and urethane groups and the hydrogen bonds with ether groups. It was also
concluded that the greater NCO:OH ratio, the more urethane-urethane hydrogen bonds were
formed [51]. An addition, R,S-PHB caused the slight increase in number of urethane-urethane
hydrogen bonds. The presence of an allophanate structures was observed at 8.5 ppm (for
aromatic PURs) and as a very small peak at 9.65 ppm (for aliphatic polyurethanes based on
PTMG).
2.2.2. Thermal properties
The presence of the synthetic R,S-PHB (with a lateral methyl group) in soft segments caused
a disturbance in the phase separation and increase the glass transition temperature (estimated
by DSC at a heating rate of 20°/min, at a temperature ranging from - 80°C to + 200°C) of the
aromatic and aliphatic PURs in comparison to PURs without R,S-PHB [61,62].
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sample Tg[°C]
Tm1
[°C]
ΔH1
[J/g]
Tm2
[°C]
ΔH2
[J/g]
PTMG -70.8 47.8 129.6 - -
PCL -60.8 68.3 84.5 - -
R,S-PHB -12.3 56.3 4.3 - -
PUR-2A-1 -67.6 - - 174.1 1.3
PUR-2A-2 -73.3 35.0 2.0 177.0 12.6
PUR-2A-3 -28.5 44.0 1.4 175.2 7.3
PUR-2A-4 -38.5 51.3 2.8 179.1 5.7
PUR-3A-1 -55.3; -10.5 37.8 0.7 107.4; 135.9; 157.5 2.5; 4.0; 2.2
PUR-3A-2 -55.3 39.8 0.8 164.5 17.0
PUR-3A-3 -32.4 50.7 3.6 90.2; 138.1 4.7; 9.1
PUR-3A-4 -49.1 50.2 19.5 107.7; 131.6; 143.0 5.0; 5.1; 2.9
Table 3. Thermal properties of oligomerols and polyurethanes (results presented in [61, 62]).
Incorporation of oligomerols into PUR structures generally increased their glass temperatures.
Moreover, using R,S-PHB for soft segment building increased the Tg of soft segments.
Obtained PURs were amorphous with the low value of crystalline phase. The introduction of
R,S-PHB into PUR structures generally reduced crystallinity of soft segments (lower melting
enthalpy was observed) [53]. In particular, it caused the reduced susceptibility of PCL to
crystallization, which was the result of partial miscibility of both oligoestroles [62].
Temperatures in the range 90°C–179°C indicated the presence of long-range order of hard
segments. A few melting endotherms on DSC thermograms (in the mentioned range) of
aliphatic PURs (series PUR-3) were probably the result of using nonlinear diisocyanate for
hard segment building. H12MDI was a mixture of stereoisomers that may be formed into
crystallites with different construction and size, and polymorphism.
The low degree of crystallinity suggested that investigated PURs could be degradable under
the conditions of a living body.
2.2.3. Microscopic observation
The surfaces of the samples and surfaces revealed after breaking of obtained PUR samples in
liquid nitrogen (cryogenically broken samples), they were tested by Transmission Electron
Microscopy (TEM) using a two-step replica.
Studies of electron microscopy of PUR samples showed that they were characterized by
varying degrees of homogeneity of the physical (morphological), depending on the chemical
composition of the polymers. For samples with reported crystallization of soft segments,
crystalline elements were usually in the form of spherulites.
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The surface of aromatic polyurethane PUR-2A series samples was smooth or only slightly
rough. The cryogenically fractured surface of these samples were homogeneous in the
micrometer scale, which indicated that the cracking (during the preparation of the samples)
occurred between the crystalline areas, and thus in the weaker points of the polymers. The
observed morphology was characteristic of non-crosslinked polymers. It was called un-radial
or “mount-depression” morphology [63].
The aliphatic PUR surfaces and their cryogenically fractured surfaces were a bit rougher than
the aromatic ones and that could influence their degradability. The surface morphology was
comparable for all investigated samples.
There were no significant differences in the morphology of the samples of PUR based on PTMG
or PCL. It was found, however, that the introduction of poly([R,S]-3-hydroxybutyrate) into the
soft segment structures resulted in a slight decrease in the roughness of the surface of test
samples and that could favorably influence the adhesion of blood elements in the study of the
effects on blood parameters of polymers [64].
2.2.4. Mechanical properties
The mechanical properties determined for the obtained PUR materials included hardness (in
degrees Shore A), tensile strength (Rr), and elongation at break (εr).
PUR Hardness[°Shore A]
Rr
[MPa]
Rr ster.
[MPa]
εr
[%]
εrster.
[%]
PUR-2A-1 82 3.5±0.1 4.6±0.3 110±10 127±6
PUR-2A-2 85 24.6±0.5 20.2±1.8 492±11 734±67
PUR-2A-3 81 9.8±0.3 7.8±0.8 532±40 537±18
PUR-2A-4 82 15.4±0.6 11.1±1.8 616±53 685±139
PUR-3A-1 80 6.9±1.9 12.0±1.2 183±81 403±74
PUR-3A-2 76 7.9±0.5 5.7±0.8 383±37 143±74
PUR-3A-3 86 8.3±1.5 9.4±1.5 361±80 287±99
PUR-3A-4 84 9.0±0.5 8.2±2.3 30±11 29±6
Table 4. The hardness and tensile strength (±standard deviation) before and after the sterilization of PURs (results
partially presented in [61,62]).
It was concluded that incorporation of R,S-PHB into aromatic and aliphatic PUR structures
slightly reduced their tensile strength and elongation. The hardness of polyurethanes was in
the range of commercial polyurethane elastomers used in medicine [61, 62].
The tensile strength of PURs obtained with the participation of the aliphatic diisocyanate
(H12MDI) was generally lower than PURs containing asymmetric and aromatic MDI. Investi‐
gations of model PURs (constructed only with H12MDI and PTMG, without chain extenders),
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indicated that in these polymers disordered hydrogen bonding were formed, making the phase
separation of soft and hard segments difficult what reduced the mechanical strength of the
materials [60].
The influence of  sample  sterilization on their  mechanical  properties  was estimated.  Gas
plasma technology (dihydrogen peroxide) was used for sterilization. In some cases, tensile
strength (Rrster.) and elongation at the break (εrster.) of samples increased after the steriliza‐
tion process. During the plasma sterilization, the free radicals were generated that could
lead to slight cross-linking chains, thereby increasing the elasticity and tensile strength of
the obtained PURs [61, 62].
2.2.5. Density
Easy penetration of water and degrading factors into the material is an important factor in the
degradation of polymers. The density of the material is one of the parameters that determine
the sorption of water.
PUR Density ±SD[g/cm3] PUR
Density ±SD
[g/cm3]
PUR-2A-1 1.098±0.024 PUR-3A-1 1.081±0.002
PUR-2A-2 1.089±0.004 PUR-3A-2 1.051±0.004
PUR-2A-3 1.189±0.007 PUR-3A-3 1.152±0.008
PUR-2A-4 1.177±0.008 PUR-3A-4 1.135±0.003
Table 5. Density of polyurethanes (results partially presented in [54, 61, 62, 65]).
2.2.6. The oil and water sorption
The implanted material, immersed into a living body is affected by surrounding solutions.
Physiological body fluids are constituted of water and floating inorganic and organic com‐
pounds, such as lipids. The tendency of water and lipids sorption by polymer is important for
its stability in natural conditions. Water plays a key role in the process of hydrolysis whereas
lipids accelerate calcification and environmental stress cracking of PUR surfaces. Moreover,
the tendency for oil sorption could predispose polymer to albumin sorption. Albumin is
peptide absorbable on implant surface what makes the natural junction with natural environ‐
ment.
The sunflower oil and water sorption by PUR samples were performed at the physiologic
temperature of the human body (37°C).
It was stated that the oil sorption by PUR samples based on PTMG and R,S-PHB was much
higher than for PURs with PCL and R,S-PHB in soft segments [65, 66].
As it was expected, aliphatic PURs (based on asymmetric diisocyanate) absorbed more oil than
aromatic ones. The oil sorption by aliphatic and aromatic PURs were significantly reduced
after the introduction of R,S-PHB into soft segments based on PTMG [61, 62]. It could suggest
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an increase the hydrophility of PURs after R,S-PHB incorporation into their structure. More‐
over, it indicated that PURs based on PTMG could be more biocompatible (according to their
affinity to lipids) than PURs with PCL.
PUR Oil sorption±SD [%]
Water sorption
PUR Oil sorption±SD [%]
Water sorption
after 24h
[%]
after 2 weeks
[%]
after 24h
[%]
after 2 weeks
[%]
PUR-2A-1 4.0±0.16 1.8 3.9 PUR-3A-1 6.9±0.28 1.3 1.5
PUR-2A-2 10.1±0.97 1.5 1.3 PUR-3A-2 13.4±0.27 2.0 1.5
PUR-2A-3 0.7±0.05 1.1 0.9 PUR-3A-3 0.7±0.01 1.1 1.1
PUR-2A-4 1.4±0.32 0.8 0.7 PUR-3A-4 0.6±0.22 0.9 1.1
Table 6. The weight changes of PUR samples after incubation in sunflower oil (results partially presented in [61, 62,
65]).
Estimated wetting angle (57°C–71°C) suggested that PURs were hydrophilic [64]. But they
absorbed a very low amount of water and only a bit higher in the case of using of PTMG for
soft segments building. As mentioned before, the glass temperature of soft segments of
polyetherurethanes and polyether-esterurethanes (Table 3) was lower than Tg of polyester‐
urethanes (PURs with PCL and PCL+R,S-PHB). Lower glass temperature was connected to
them being less stiff than polyesterurethanes [67]. In case when the chains were stiff, their
mobility was reduced so water could not penetrate easy between them. Higher water absorp‐
tion by PURs based on PTMG could suggest their higher susceptibility to degradation in
aqueous medium. In a PUR network, the particles (such as free radicals and enzymes) that
could facilitate its degradation may penetrate with the water.
The presence of R,S-PHB in soft segments increased the water sorption of aromatic PURs [61].
2.2.7. Bacteriostatic properties
The influence of polyurethane PUR-3A-3 on microorganisms (Staphylococcus aureus, Escherichia
coli, and Candida albicans) was investigated using disk methods [68, 69]. The Staphylococcus
aureus growth around PUR samples was the most inhibited. The bacterial growth was inhibited
for 6 mm around a circle sample (diameter of the sample was 8 mm). Knowing that 3-
hydroxybutyrate belonging to fatty acids revealed antibacterial activity, it was concluded that
R,S-PHB was responsible for the decreasing microorganism growth [68]. But the determined
number of survival Staphylococcus aureus bacteria directly contacted with PUR sample
PUR-3A-3 in a tube method showed only slight decrease of bacteria quantity in comparison
to control probe [69]. It suggested its bacteriostatic but no bactericidal properties.
2.2.8. Hemocompatibility
Hemocompatibility of obtained PURs was estimated by observations of changes in morphol‐
ogy and coagulation parameters of whole blood after 4 h of direct contact with polymer
samples using flow cytometry and photooptical methods [64, 65].
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Parameter [unit] PUR-2A-3 PUR-3A-1 PUR-3A-3 Blood samplewithout PUR Reference value
WBC [*103/μl] 6.0 5.9 6.1 6.1 4.0-10.0
RBC [*106/ μl] 4.4 4.4 4.4 4.3 4.0-5.0
HGB [g/dl] 12.6 12.7 12.6 12.2 12.0-16.0
HCT [%] 38.1 38.8 37.9 38.0 37.0-47.0
MCV [fl] 87.6 88.0 87.4 87.2 80.0-96.0
MCH [pg] 28.8 28.8 28.8 28.8 27.0-32.0
MCHC [g/dl] 32.9 32.7 33.0 33.0 31.0-36.0
RDW [%] 13.7 13.8 13.9 13.7 11.5-14.5
PLT [*103/μl] 255.5 253.4 246.8 247 140.0-400.0
MPV [fl] 9.5 11.3 10.7 9.4 7.0-12.0
APTT [RATIO] 31.3 36.5 29.4 29.8 26.0-37.0
FIBR [g/l] 3.2 1.2 3.5 3.4 1.5-4.5
Table 7. Blood parameters after direct contact with PUR samples and those without contact.
The values of hematologic parameters before and after the incubation of PUR samples in blood
were in reference ranges. Differences in comparison to the control probe were not observed
that suggests the lack of hemolysis activated by polyurethane presence. Insignificant changes
in platelet and fibrinogen concentration and in APPT during direct contact of blood with
polymer samples suggested that polyurethanes based on synthetic poly([R,S]-3-hydroxybu‐
tyrate) could be atrombogenic [65].
2.2.9. Degradability
The influence of the surrounding environment on implanted material can be simulated using
hydrolytic and oxidative solutions. Also, simulated body fluids (SBF) and Ringer solutions
included ions that could be found in natural fluids are often used for estimation of biomaterials
degradability.
Deionized water or phosphate buffer solution (PBS) is generally used for obtaining hydrolytic
conditions in investigations of polymers degradation. According to Christenson et al. [70], the
degradation of PURs in a solution of CoCl2/H2O2 effectively reflected the oxidation occurring
in the living body. The similar changes in the structure of the polymers after one year implan‐
tation in the body of rats and after 24-day action of the oxidation mixture were observed. It
has been found that the arrangement of CoCl2/H2O2 degraded the soft segments of the
polyetherurethanes 17 times faster and the polycarbonate urethanes - 14 times [70]. Aliphatic
PUR were also degraded in SBF and Ringer solution.
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PUR
The weight changes ±SD [%]
36 weeks of
incubation in PBS
16 weeks of incubation
inCoCl2/H2O2
36 weeks of incubation
in SBF
36 weeks of incubation
in Ringer
PUR-2A-1 -1.4±0.1 -22.4±0.9
not estimated
PUR-2A-2 0.4±0.3 -34.3±0.5
PUR-2A-3 -3.2±0.1 -30.2±3.3
PUR-2A-4 0.9±0.2 -7.5±0.7
PUR-3A-1 -60.3±13.2 -70.9±1.7 disintegration -16.1±3.5
PUR-3A-2 -55.2±2.3 -29.7±4.3 10.0±2.5 -0.8±0.1
PUR-3A-3 -5.2±0.1 -11.2±0.4 -36.6±1.8 -13.6±0.1
PUR-3A-4 1.4±0.1 -8.2±0.1 6.2±1.0 -1.2±0.3
Table 8. The weight changes of PUR samples after incubation (at 37°C) in phosphate buffer solution (PBS), oxidative
solution (CoCl2/H2O2), simulated body fluids (SBF), and Ringer solution (Ringer) (results partially presented in [52, 54,
71]).
The susceptibility to hydrolytic and oxidative degradation of obtained PUR with synthetic
poly([R,S]-3-hydroxybutyrate) indicated that these materials were more sensitive to the
oxidative than hydrolytic conditions. Using an aliphatic diisocyanate in the synthesis (instead
of aromatic) increased the susceptibility of PURs to degradation, especially in hydrolytic
environments. More susceptible to degradation processes were PUR with PTMG than PCL in
soft segment [71].
Introduction of R,S-PHB into the soft segments increased the rate of degradation in all
investigated solutions. Aliphatic PURs based on R,S-PHB and PTMG appeared as the most
sensitive to conditions of all degradative solutions (higher sample mass loss and molecular
weight reduction were noticed) [54].
In some cases, after 36 weeks of incubation the sample mass did not change significantly or
even increased. The observed molecular weight reduction after incubation of PURs based on
PCL in phosphate buffer indicated that ester linkages were hydrolyzed but because of the
insolubility of PCL products, they were not rinsed polymer bulk [54]. Mondal et al. [55]
suggested that the degradation products could be retained in bulk films by hydrogen bonding,
van der Waals force, polar interaction, etc.
Meanwhile, increasing of sample mass of PUR-3A-2 and PUR-3A-4 after incubation in SBF was
probably the result of salts molecules trapping between the macrochains of the polymer
network what influenced on the samples mass [52]. Moreover, according to microscope
observations of polymer samples presented earlier presence of R,S-PHB in soft segments of
PURs protected them against the salt sediments.
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Degradability of PURs with R,S-PHB in soft segments could be also controlled by their mixing
with PLA [66]. The presence of PLA in polyurethane blends accelerated their degradation in
hydrolytic, trypsin, and lipase solutions. The significant reduction of molecular weight of
polymer samples after incubation in phosphate buffer and the lack of mass changes after
incubation in enzyme solutions suggested that polyurethanes and their blends were degraded
via chemical hydrolysis. The investigations of morphology of the surface structure, which was
changed after the incubation in both enzymes indicated that the enzymatic hydrolysis had
been already initiated [66].
2.2.10. Electrospinning
DSC and WAXS results indicated that similar PURs (with molar ratio of NCO:OH=2:1 in
prepolymer) containing PCL in soft segments had higher ability for crystallization than those
having PTMG in soft segments [53]. It was the reason why PURs containing PTMG and R,S-
PHB in soft segments was chosen for electrospinning. Polymer appeared as spinnable in an
electric field, with thermal stability (no phase transitions) in the temperature range up to 95°C.
Electrospinning of polyether-esterurethane from hexafluoro-2-propanole solution resulted in
the formation of fibers with an average diameter ca. 2 μm. [53].
3. Conclusion
It could be stated that PURs based on synthetic poly([R,S]-3-hydroxybutyrate) displayed the
properties appropriate for further investigations for medical applications such as degradable
scaffolds. Properties of presented polyester- and polyester-etherurethanes suggest that they
could be biocompatible, biostatic, and biodegradable under conditions of living body envi‐
ronment. It suggests also that aromatic diisocyanate may be successfully replaced by an
aliphatic one. Incorporation of synthetic polyhydroxybutyrate into soft segments of PURs
decreased their degree of crystallinity and increased degradability.
Using polycaprolactonediol for PUR synthesis is appropriate for the design of material
undergoing slow and gradual degradation in living body. Higher oil sorption and faster rate
of degradation of aliphatic PURs based on polyoxytetramethylenediol promote it for being
used as biodegradable scaffolds with hydrophobic active substance.
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